In order to evaluate the application of PAT tools to the development and commercialization of a bioprocess, BioPhorum conducted a benchmarking survey of biopharmaceutical companies and published the results in Biotechnology and Bioengineering journal. The results obtained in the survey can guide scientists and new manufacturers in terms of quality product development and all the stakeholders including funding agencies to assess the business value of tools and techniques employed during biologics manufacturing. This article published in Medicine Innovates is a synopsis of the paper
process technology
Viewing related articles
Systematic assessment of process analytical technologies for biologics
Nov 2021 | Deliverable, Development Group, PAT Monitoring and Control, Publication
To evaluate the application of PAT tools to the development and commercialization of a bioprocess, BioPhorum conducted a benchmarking survey of biopharmaceutical companies and published the results in Biotechnology and Bioengineering journal. Investigators assessed fifteen companies receiving seventeen responses from them and evaluated more than 20 different types of PAT tools in manufacturing using an industry-wide assessment to identify and rank the tools based on technological attributes such as technology maturity, ability to enable process control, and ease of implementation, as well as their business value such as simplicity of implementation, lead time, and cost reduction.
Enablers and blockers to the implementation of APC/PA solutions
Oct 2021 | Information Technology, Publication
A BioPhorum member only resource examining the enablers and blockers to the implementation of APC/PA solutions.
Implementation of PAT survey summary and vendor technical presentations
Oct 2021 | Benchmarking, Development Group, PAT Monitoring and Control
A BioPhorum member only benchmarking survey looking at the converting the implementation of PAT for Raman and flow VPE technologies
Biomanufacturing technology roadmap: 3. Process technologies
May 2017 | POI - Technology Strategy, Technology Strategy
This chapter of the first edition biomanufacturing technology roadmap published in 2017, describes the vision, scope and benefits that could be gained in the biopharmaceutical manufacturing industry from the development and adoption of effective process technologies. To help the industry achieve this future state it describes the scenarios considered, the future needs, challenges and potential solutions as well as the linkages and dependencies on other parts of the roadmap. It considers the contribution that disruptive and emerging technologies can play and regulatory considerations before finalizing with conclusions and recommendations.